Skip to main content
Clinical Trials/NCT05516186
NCT05516186
Completed
Not Applicable

Effects of a Scapular-focused Exercise Protocol for Patients With Rotator Cuff Related Pain Syndrome - a Randomized Clinical Trial

NOVA School of Science and Technology ı FCT NOVA1 site in 1 country60 target enrollmentMay 9, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Rotator Cuff Syndrome of Shoulder and Allied Disorders
Sponsor
NOVA School of Science and Technology ı FCT NOVA
Enrollment
60
Locations
1
Primary Endpoint
DASH disabilities of the arm, shoulder and hand
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Background: Current clinical practice still lacks consistent evidence in the physiotherapy management of Rotator cuff related pain syndrome (RCS). The purpose of this trial was to compare the effectiveness of a scapular-focused treatment with and without real-time electromyographic biofeedback (EMGBF) to a control therapy in patients with RCS.

Methods: 60 patients with RCS were divided into three groups: scapular-focused exercise protocol group (P_G n=20), scapular-focused exercise protocol with EMGBF group (P+EMGBF_G n=20) and control therapy group (CT_G n=20). Values of pain and function [Shoulder Pain and Disability Index (SPADI) questionnaire, complemented by the Numeric Pain Rating Scale (NPRS) and Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire], scapular stabilizer neuromuscular control (SSNC), scapular stabilizer activation onset (SSAO), dynamic scapular alignment, range of motion (ROM) and glenohumeral flexor and abductor muscle strength (GMS) were assessed at baseline and after 6-weeks and compared within and between groups.

Detailed Description

In order to advance the understanding of the value of scapular-focused exercise for rotator cuff related syndrome, a new trial was designed with the main objective of comparing pain and function outcomes between three different treatment protocols for patients with RCS: P_G - Scapular-focused exercise protocol without electromyographic biofeedback (EMGBF) P+EMGBF_G - Scapular-focused exercise protocol supported by real-time EMGBF CT_G - Control therapy group with manual therapy (glenohumeral joint physiologic and accessory mobilization) , massage to reduce upper trapezius (UT) stiffness, and shoulder rotation strengthening into external rotation Every outcomes was assessed at the beginning of treatment, and then, weekly until completed 6 weeks of treatment.

Registry
clinicaltrials.gov
Start Date
May 9, 2022
End Date
July 25, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
NOVA School of Science and Technology ı FCT NOVA
Responsible Party
Principal Investigator
Principal Investigator

Ricardo Matias

PhD

NOVA School of Science and Technology ı FCT NOVA

Eligibility Criteria

Inclusion Criteria

  • 1- age between 18 and 60 years; 2 - primary complaint of shoulder pain 3 - RCS clinical diagnosis

Exclusion Criteria

  • neurological symptoms;
  • positive thoracic outlet syndrome (screened with Allen's and Adson's tests);
  • history of shoulder surgery or fracture;
  • structural injuries confirmed by imaging (e.g. ligaments and labrum);
  • symptoms reproduced by cervical examination;
  • unable to commit to scheduled treatments;
  • Anti-inflammatory drug use

Outcomes

Primary Outcomes

DASH disabilities of the arm, shoulder and hand

Time Frame: At 6 weeks after the treatment protocol (final assessment)

From zero (better score) to 100 (worst score)

NPRS numeric pain rating scale

Time Frame: At 6 weeks after the treatment protocol (final assessment)

From zero (better score) to 10 (worst score)

SPADI shoulder pain and disability index

Time Frame: At 6 weeks after the treatment protocol (final assessment)

From zero (better score) to 100 (worst score)

Secondary Outcomes

  • dynamic scapular alignment(At 6 weeks after the treatment protocol (final assessment))
  • range of motion(At 6 weeks after the treatment protocol (final assessment))
  • scapular stabilizer activation onset(At 6 weeks after the treatment protocol (final assessment))
  • scapular stabilizer neuromuscular control(At 6 weeks after the treatment protocol (final assessment))
  • glenohumeral flexor and abductor muscle strength(At 6 weeks after the treatment protocol (final assessment))

Study Sites (1)

Loading locations...

Similar Trials